Sign in

CIK 0001755237

  • Non-accelerated filer
  • Smaller reporting company

Korsana Biosciences, Inc.

Sign in to watch
Ticker
KRSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
831895370
Phone
+1 781-516-2325
Business address
203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
Former names
Cyclerion Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Financial Officer sold 3,559 shares at $5.12 ($18,222)
  5. 4 Open-market sale President sold 50,000 shares at an average $2.52 ($125,750)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Chief Innovation Officer bought 125,000 shares at $1.82 ($227,500)
  11. 4 Open-market sale Chief Financial Officer sold 3,922 shares at $2.05 ($8,040)
  12. 4/A Grant or award Chief Executive Officer acquired 221,736 shares (grant or award)
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Grant or award Chief Financial Officer acquired 77,492 shares (grant or award)
  15. 4 Exercise or conversion Chief Executive Officer acquired 2,000 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 7 · 134 filings